Furthermore, the authors showed that FGF5 secreted by cancer-associated fibroblasts (CAF) in the microenvironment might be responsible for the high activation of FGFR2 on the neighboring epithelial cells [54], confirming the potential signaling switch between HER2 and FGFR2 in breast cancer. This evidence concerns the gene ERBB2 and breast cancer.